DR. NADEEM YOUSAF ALI M.D. NPI 1922374750

NPI Details

DR. Nadeem Yousaf Ali, M.D. is a pulmonary disease internal medicine in Hackensack, NJ with 16 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. DR. Nadeem Yousaf Ali, M.D. NPI is 1922374750. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

211 ESSEX ST
SUITE 302
HACKENSACK, NJ
ZIP 07601-231
Phone: (201) 498-1321

The NPI 1922374750 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Test to determine lung volumes using gas dilution or washout (HCPCS:94727)
• Test to examine how well the lungs exchange gases (HCPCS:94729)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Biopsy of lobe of lung using an endoscope, 1 lobe (HCPCS:31628)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Irrigation and suction of lung airways to obtain cells using an endoscope (HCPCS:31624)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes (HCPCS:31652)
• Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound (HCPCS:31654)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Aspiration of fluid from chest cavity using imaging guidance (HCPCS:32555)

The enumeration date for this NPI number is 3/27/2012 and was last updated on 3/9/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: